Original Research
Published on 09 Sep 2024
Unraveling the regulatory cell death pathways in gastric cancer: a multi-omics study
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1447970
- 644 views
Type at least 3 characters
1,085 articles
Articles
Original Research
Published on 09 Sep 2024
Chitosan/hesperidin nanoparticles formulation: a promising approach against ethanol-induced gastric ulcers via Sirt1/FOXO1/PGC-1α/HO-1 pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433793
- 1,019 views
Systematic Review
Published on 09 Sep 2024
Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1420455
- 915 views
Review
Published on 06 Sep 2024
Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1380878
- 1,187 views
Original Research
Published on 04 Sep 2024
STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454829
- 1,093 views
Original Research
Published on 04 Sep 2024
Current status and influencing factors of prophylactic use of proton pump inhibitors in internal medicine inpatients receiving glucocorticoid therapy
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418086
- 521 views
Review
Published on 03 Sep 2024
Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1463187
- 1,492 views
Original Research
Published on 03 Sep 2024
The different effects of four adenosine receptors in liver fibrosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1424624
- 652 views
Original Research
Published on 02 Sep 2024
Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1443555
- 1,227 views
Original Research
Published on 27 Aug 2024
Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn’s disease
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430120
- 534 views
Brief Research Report
Published on 19 Aug 2024
The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407228
- 963 views
Brief Research Report
Published on 16 Aug 2024
Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1453595
- 787 views
- 1 citation
Correction
Published on 15 Aug 2024
Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1395496
- 457 views
Systematic Review
Published on 15 Aug 2024
Effects of perioperative steroid use on surgical stress and prognosis in patients undergoing hepatectomy: a systematic review and meta-analysis of randomized controlled trials
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415011
- 548 views
Original Research
Published on 13 Aug 2024
Thonningianin A ameliorated renal interstitial fibrosis in diabetic nephropathy mice by modulating gut microbiota dysbiosis and repressing inflammation
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389654
- 1,354 views
Original Research
Published on 13 Aug 2024
CPS1 augments hepatic glucagon response through CaMKII/FOXO1 pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1437738
- 746 views